Better Buy: Amgen Inc. vs. Biogen

Better Buy: Amgen Inc. vs. Biogen


Which of these two stocks is the better pick for investors headed into the new year? Here's how Amgen and Biogen compare. First, the bad news for Amgen: Sales of its top drug, Enbrel, were flat in the last quarter compared with the prior-year period.



from Biotech News